1. An in vivo murine model of rosiglitazone use in pregnancy
Denise B. Klinkner, M.D., Hyun J. Lim, Ph.D., Estil Y. Strawn, M.D., Keith T. Oldham, M.D., Tara L. Sander, Ph.D. 
Fertility and Sterility 
Volume 86, Issue 4, Pages (October 2006)
DOI: /j.fertnstert
Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

2. FIGURE 1
Rosiglitazone effect on embryogenesis. Two-cell murine embryos were treated with 10 μM rosiglitazone for 72 hours and then scored for stage of blastocyst development and compared with dimethyl sulfoxide carrier control. Of the control embryos, 100% reached blastocyst stage, and 100% of the rosiglitazone-treated embryos reached blastocyst stage. None of the diethyl maleate embryos reached blastocyst stage.
Klinkner. Rosiglitazone use in murine pregnancy. Fertil Steril 2006.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions

3. FIGURE 2
Mean weekly pup weights. Weights were obtained weekly on control (C), rosiglitazone (R), and human-dosaged–rosiglitazone (HR) pups. No differences were observed between groups. (Analysis of variance with Bonferroni adjustment, P>.05).
Klinkner. Rosiglitazone use in murine pregnancy. Fertil Steril 2006.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2006 American Society for Reproductive Medicine Terms and Conditions